Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Jul 21;324(3):291-292.
doi: 10.1001/jama.2020.9246.

Medications for Primary Prevention of Breast Cancer

Affiliations
Review

Medications for Primary Prevention of Breast Cancer

Yiwey Shieh et al. JAMA. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Drs. Shieh and Tice report no conflicts of interest.

Figures

Figure.
Figure.
Suggested Approach to Choosing Medication for Breast Cancer Risk Reduction

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA: a cancer journal for clinicians. 2020;70(1):7–30. - PubMed
    1. Cuzick J, Sestak I, Cawthorn S, et al. Tamoxifen for prevention of breast cancer: extended long-term follow-up of the IBIS-I breast cancer prevention trial. Lancet Oncol. 2015;16(1):67–75. - PMC - PubMed
    1. Thorneloe RJ, Horne R, Side L, Wolf MS, Smith SG. Beliefs About Medication and Uptake of Preventive Therapy in Women at Increased Risk of Breast Cancer: Results From a Multicenter Prospective Study. Clin Breast Cancer. 2019;19(1):e116–e126. - PMC - PubMed
    1. McCarthy AM, Guan Z, Welch M, et al. Performance of breast cancer risk assessment models in a large mammography cohort. Journal of the National Cancer Institute. 2019:djz177. - PMC - PubMed
    1. U. S. Preventive Services Task Force. Medication Use to Reduce Risk of Breast Cancer: US Preventive Services Task Force Recommendation Statement. Jama. 2019;322(9):857–867. - PubMed

MeSH terms